Dr. Jakeman discusses the organization of the NIH and its role in funding of research programs on spinal cord injury and related topics. The talk will include an overview of the landscape of spinal cord injury research program support and a snapshot of what the NIH research portfolio looks like today. The audience should get a sense of the wide range of research opportunities that are available and will learn about the rich supply of valuable resources that are available for the both the general public and for active researchers.Dr. Lyn Jakeman is a Program Director overseeing extramural research on spinal cord injury (SCI) and peripheral nerve repair at the National Institute of Neurological Disorders and Stroke (NINDS). She earned a B.A. in Biology from Hartwick College in Oneonta, New York and a Ph.D. in Neuroscience from the University of Florida, where she studied embryonic spinal cord grafts in rodent SCI models. Dr. Jakeman did postdoctoral training at Genentech, Inc., and worked at the in the Neuropharmacology Department at Syntex Research in Palo Alto, California. To get back to full time SCI research, she returned to an academic setting in the Physiology Department at the Ohio State University and was there for 17 years. Her laboratory focused on the responses of glial cells and the role of changes in the extracellular matrix following SCI. While at OSU, she also participated in the NINDS annual spinal cord injury training program and the translational study replication contracts.
- Airline lobby wins another big delay on reporting data for wheelchair damages and losses *January 2019*
- An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling
- 17th International Symposium on Neural Regeneration
- Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury
- Gait Rehabilitation with a Neurologically Controlled Exoskeleton
- Nanoparticles limit damage in spinal cord injury
- It’s Not a Rat’s Race for Human Stem Cells Grafted to Repair Spinal Cord Injuries
- It’s On! U2FP Working 2 Walk 2017 and SCI Curecast Episode 11
- InVivo Therapeutics restructures and suspends chronic SCI stem cell and gene therapy research programs
- Pretreatment May Unlock the Regenerative Potential of Neural Stem Cells in Chronic Spinal Cord Injury
- Regulateable Chondroitinase ABC gene therapy as a treatment for spinal cord injury
- Miracle chemical ‘cocktail’ could cure spinal cord damage
- Combined expression of pro-regenerative transcription factors and transplanted stem cells to promote corticospinal tract regeneration.
- Structural and Functional Substitution of Deleted Primary Sensory Neurons by New Growth from Intrinsic Spinal Cord Nerve Cells: An Alternative Concept in Reconstruction of Spinal Cord Circuits
- U2FP SCI CureCast now includes the 8th episode!
Follow on TwitterMy Tweets